Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

3.8K
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.4K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.4K
Accessory Glands of the Male Reproductive System01:16

Accessory Glands of the Male Reproductive System

4.4K
The accessory ducts involved in sperm maturation and transportation include the epididymides, vasa deferentia, ejaculatory ducts, and urethra. These ducts play a critical role in the maturation, storage, and transportation of sperm from the testes to the urethra, where it is then released during ejaculation.
The epididymis is a small, comma-shaped organ located at the back of each testicle. The epididymis can be divided into three main parts: the head, body, and tail. The head of the epididymis...
4.4K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

591
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
591
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

697
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
697

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Long-Term Outcomes of Rezūm Therapy for Large-Volume Benign Prostatic Hyperplasia: A Multicenter Cohort Study.

Lower urinary tract symptoms·2026
Same author

Predictors of surgical retreatment following Rezūm water vapor therapy: a multi-center real-world cohort study.

World journal of urology·2026
Same author

Outcomes of Rezūm therapy in young men: A multi-center study.

Urologia·2026
Same author

Polypropylene mesh degradation and systemic disease: biological plausibility is not clinical evidence.

Nature reviews. Urology·2026
Same author

Healthcare disparities and pelvic organ prolapse operative complications: a nationwide analysis.

Gynecology and pelvic medicine·2026
Same author

Health Care Sustainability: Strategies for Operating Rooms and Urogynecologic Procedures.

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.8K

Benign prostatic hyperplasia.

Bilal Chughtai1, James C Forde1, Dominique Dana Marie Thomas1

  • 1Department of Urology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York, USA.

Nature Reviews. Disease Primers
|May 6, 2016
PubMed
Summary
This summary is machine-generated.

Benign prostatic hyperplasia (BPH), a common condition in aging men causing lower urinary tract symptoms (LUTS), involves prostate enlargement due to cell proliferation. Treatment for BPH and LUTS ranges from watchful waiting to medical and surgical interventions based on symptom severity.

More Related Videos

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.5K
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

20.5K

Related Experiment Videos

Last Updated: Mar 21, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.8K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.5K
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

20.5K

Area of Science:

  • Urology
  • Andrology
  • Gerontology

Background:

  • Benign prostatic hyperplasia (BPH) is a prevalent condition in aging males, characterized by lower urinary tract symptoms (LUTS).
  • Risk factors, both modifiable and non-modifiable, contribute to BPH and LUTS development and progression.
  • BPH involves prostate enlargement due to stromal and epithelial cell proliferation, influenced by inflammation and sex hormones.

Purpose of the Study:

  • To provide a comprehensive overview of benign prostatic hyperplasia (BPH) and its associated lower urinary tract symptoms (LUTS).
  • To discuss the risk factors, diagnostic approaches, and treatment modalities for BPH.
  • To highlight the factors influencing the initial treatment pathway for patients with BPH and LUTS.

Main Methods:

  • Review of existing literature on benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
  • Analysis of the pathophysiology, clinical presentation, and diagnostic workup for BPH.
  • Examination of the spectrum of treatment options available for BPH, from conservative to interventional.

Main Results:

  • BPH presents with obstructive, irritative, or post-micturition symptoms.
  • Diagnosis of BPH involves key investigations for patients experiencing LUTS.
  • Treatment selection for BPH is guided by symptom severity and patient bother.

Conclusions:

  • Benign prostatic hyperplasia (BPH) is a common, progressive condition in aging men, necessitating a clear understanding of its management.
  • Effective management of BPH and LUTS requires accurate diagnosis and tailored treatment strategies.
  • The choice of intervention for BPH is individualized, prioritizing symptom relief and quality of life.